Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 16, 2022; 10(20): 6825-6844
Published online Jul 16, 2022. doi: 10.12998/wjcc.v10.i20.6825
Table 3 Complete blood count ratios at least 4-6 weeks after primary tumor removal surgery (n = 644)
Parameter
mean ± SD
Number of missing
Available %
Time since tumor removal surgery (mo)2.21 ± 1.88
Lymphocyte-to-monocyte ratio4.01 ± 1.9510782.49%
Neutrophil-to-lymphocyte ratio3.59 ± 2.8227355.32%
Hemoglobin-to-platelet ratio0.48 ± 0.190100%
Red blood cell distribution width-to-platelet ratio0.058 ± 0.02321265.30%
Platelet-to-lymphocyte ratio67.60 ± 28.8226656.46%
Personalized platelet count, relative to “at-diagnosis” 0.91 ± 0.270100%